The current mission of the AI lab for Biofabrication and Disease Modelling is to develop and implement AI-based technologies for use in microscopy, bioprinting, and automation. Patient-derived living cell technologies play a critical role in preclinical biomedical research and may enable the development of personalized, regenerative, and curative treatments.  The combination of new emerging AI techniques in the field of computer vision and multivariate modelling, with such living cell technologies will be critical to further drive the impact of these living technologies from the fundamental to clinical domain.